This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NorDx Enhances Clinical Laboratory Diagnostic Services With State-of-the-Art Technology

PORTLAND, Maine, April 3, 2013 /PRNewswire/ --  NorDx, (Northern Diagnostic Laboratories), the largest reference laboratory in the state of Maine and a member of MaineHealth, today announces the acquisition of Sysmex® XN-Series Automated Hematology Analyzers.  NorDx and MaineHealth are the first clinical laboratories in the country to acquire the new Sysmex XN-Series hematology analyzers.  The analyzers enhance the clinical laboratories' turnaround times for patient blood counts results, thereby enabling physicians and other healthcare professionals to treat patients sooner, according to Stan Schofield, President of NorDx, Senior Vice President of MaineHealth.  The analyzers also offer unique advantages for testing both normal and abnormal hematology samples.  "Our clinical laboratories will now be able to further improve differentiation of anemia types, better monitor bone marrow transplants, better aid in the diagnoses of leukemia and other diseases with immature cells in the circulating blood and help improve the diagnosis of possible bleeding disorders," added Schofield.  NorDx is accredited by the College of American Pathologists and offers a full range of laboratory services to multiple hospital sites, physician practices, and long-term care facilities in the tri-state region of Maine, New Hampshire and Vermont.  

"As a member of one of the nation's top 100 integrated delivery networks, we understand that our clinical excellence starts with the core technology and clinical utility of our laboratory's instrumentation and ends with diagnosis, treatment and improved quality of life for the patient," said Schofield.  "The Sysmex® XN-Series is a powerful new technology platform that sets an entirely new standard of testing sophistication and capacity.  No doubt, these new analyzers have broad implications for the health and vitality of our community considering much of a patient's medical record is comprised of laboratory results," added Schofield. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs